ZA200100124B - Method for determining polynucleotide sequence variations. - Google Patents
Method for determining polynucleotide sequence variations. Download PDFInfo
- Publication number
- ZA200100124B ZA200100124B ZA200100124A ZA200100124A ZA200100124B ZA 200100124 B ZA200100124 B ZA 200100124B ZA 200100124 A ZA200100124 A ZA 200100124A ZA 200100124 A ZA200100124 A ZA 200100124A ZA 200100124 B ZA200100124 B ZA 200100124B
- Authority
- ZA
- South Africa
- Prior art keywords
- label
- terminator
- primer
- polynucleotide
- labeled
- Prior art date
Links
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 153
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 153
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 153
- 238000000034 method Methods 0.000 title claims abstract description 124
- 239000002773 nucleotide Substances 0.000 claims abstract description 79
- 239000012634 fragment Substances 0.000 claims abstract description 78
- 238000006243 chemical reaction Methods 0.000 claims abstract description 55
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 55
- 230000003321 amplification Effects 0.000 claims abstract description 39
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 39
- 235000011178 triphosphate Nutrition 0.000 claims description 28
- 239000001226 triphosphate Substances 0.000 claims description 28
- HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 claims description 12
- ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 claims description 12
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 claims description 9
- 238000003757 reverse transcription PCR Methods 0.000 claims description 7
- OTXOHOIOFJSIFX-POYBYMJQSA-N [[(2s,5r)-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)O)CC[C@@H]1N1C(=O)NC(=O)C=C1 OTXOHOIOFJSIFX-POYBYMJQSA-N 0.000 claims description 5
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 5
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 5
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 5
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 5
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 4
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 claims description 4
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 239000002213 purine nucleotide Substances 0.000 claims description 3
- 150000003212 purines Chemical class 0.000 claims description 3
- 239000002719 pyrimidine nucleotide Substances 0.000 claims description 3
- 150000003230 pyrimidines Chemical class 0.000 claims description 3
- -1 nucleotide triphosphates Chemical class 0.000 claims 24
- 239000007795 chemical reaction product Substances 0.000 claims 2
- 239000004927 clay Substances 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000000746 purification Methods 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- UFJPAQSLHAGEBL-RRKCRQDMSA-N dITP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(N=CNC2=O)=C2N=C1 UFJPAQSLHAGEBL-RRKCRQDMSA-N 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000005546 dideoxynucleotide Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000007692 polyacrylamide-agarose gel electrophoresis Methods 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Error Detection And Correction (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9713698P | 1998-08-19 | 1998-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200100124B true ZA200100124B (en) | 2001-08-03 |
Family
ID=22261392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200100124A ZA200100124B (en) | 1998-08-19 | 2001-01-05 | Method for determining polynucleotide sequence variations. |
Country Status (13)
Country | Link |
---|---|
US (2) | US6322988B1 (de) |
EP (1) | EP1105537B1 (de) |
JP (1) | JP3949378B2 (de) |
CN (1) | CN1197975C (de) |
AT (1) | ATE310103T1 (de) |
AU (1) | AU737087C (de) |
CA (1) | CA2336546A1 (de) |
DE (1) | DE69928409D1 (de) |
HK (1) | HK1040265A1 (de) |
IL (1) | IL141329A (de) |
IS (1) | IS5847A (de) |
WO (1) | WO2000011221A1 (de) |
ZA (1) | ZA200100124B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030138834A1 (en) * | 1998-08-19 | 2003-07-24 | Dawson Elliott P. | Method for determining polynucleotide sequence variations |
US20040121394A1 (en) * | 1998-08-19 | 2004-06-24 | Dawson Elliott P. | Method for determining polynucleotide sequence variations |
WO2002072892A1 (en) * | 2001-03-12 | 2002-09-19 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
US9261460B2 (en) * | 2002-03-12 | 2016-02-16 | Enzo Life Sciences, Inc. | Real-time nucleic acid detection processes and compositions |
EP2184369A1 (de) | 2001-07-11 | 2010-05-12 | Applied Biosystems, LLC | Verfahren zur Normalisierung in der Elektrophorese |
EP1442137A4 (de) | 2001-11-07 | 2005-08-31 | Applera Corp | Universelle nukleotide für die nukleinsäureanalyse |
US9353405B2 (en) | 2002-03-12 | 2016-05-31 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
US7189512B2 (en) * | 2003-02-20 | 2007-03-13 | Noga Porat | Methods for variation detection |
JP5037343B2 (ja) * | 2004-06-10 | 2012-09-26 | ジーイー・ヘルスケア・バイオサイエンス・コーポレイション | 核酸分析方法 |
EP1798291B1 (de) * | 2005-12-13 | 2011-05-18 | Institut Curie | Verfahren für die Detektion von Mutationen in Nukleinsaüren, und die Anwendung in der Diagnose von genetischen Krankheiten und Krebs |
IT1397110B1 (it) * | 2008-12-29 | 2012-12-28 | St Microelectronics Rousset | Microreattore autosigillante e metodo per eseguire una reazione |
CN105874460B (zh) * | 2013-11-01 | 2018-10-02 | 精赛恩公司 | 识别靶序列的至少一个碱基的方法、可读介质及设备 |
CN114724628B (zh) * | 2022-04-24 | 2022-11-08 | 华中农业大学 | 一种对多物种进行多核苷酸变异鉴定和注释的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5683869A (en) * | 1993-09-03 | 1997-11-04 | Duke University | Method of nucleic acid sequencing |
AU2766195A (en) * | 1994-06-03 | 1996-01-05 | Brigham And Women's Hospital | Identification of polycystic kidney disease gene, diagnostics and treatment |
US5830657A (en) * | 1996-05-01 | 1998-11-03 | Visible Genetics Inc. | Method for single-tube sequencing of nucleic acid polymers |
US6432634B1 (en) * | 1996-04-18 | 2002-08-13 | Visible Genetics Inc. | Method, apparatus and kits for sequencing of nucleic acids using multiple dyes |
US5847162A (en) * | 1996-06-27 | 1998-12-08 | The Perkin Elmer Corporation | 4, 7-Dichlororhodamine dyes |
US5928906A (en) * | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
US5846727A (en) * | 1996-06-06 | 1998-12-08 | Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College | Microsystem for rapid DNA sequencing |
-
1999
- 1999-08-19 US US09/719,130 patent/US6322988B1/en not_active Expired - Fee Related
- 1999-08-19 AU AU56813/99A patent/AU737087C/en not_active Ceased
- 1999-08-19 EP EP99943782A patent/EP1105537B1/de not_active Expired - Lifetime
- 1999-08-19 CN CNB99809692XA patent/CN1197975C/zh not_active Expired - Fee Related
- 1999-08-19 CA CA002336546A patent/CA2336546A1/en not_active Abandoned
- 1999-08-19 DE DE69928409T patent/DE69928409D1/de not_active Expired - Lifetime
- 1999-08-19 AT AT99943782T patent/ATE310103T1/de not_active IP Right Cessation
- 1999-08-19 JP JP2000566472A patent/JP3949378B2/ja not_active Expired - Fee Related
- 1999-08-19 WO PCT/US1999/018965 patent/WO2000011221A1/en active IP Right Grant
- 1999-08-19 IL IL14132999A patent/IL141329A/xx not_active IP Right Cessation
-
2001
- 2001-01-05 ZA ZA200100124A patent/ZA200100124B/en unknown
- 2001-02-16 IS IS5847A patent/IS5847A/is unknown
- 2001-11-26 US US09/994,119 patent/US20020164606A1/en not_active Abandoned
-
2002
- 2002-02-28 HK HK02101568A patent/HK1040265A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1040265A1 (en) | 2002-05-31 |
IL141329A (en) | 2005-07-25 |
JP3949378B2 (ja) | 2007-07-25 |
ATE310103T1 (de) | 2005-12-15 |
CA2336546A1 (en) | 2000-03-02 |
IS5847A (is) | 2001-02-16 |
DE69928409D1 (de) | 2005-12-22 |
EP1105537B1 (de) | 2005-11-16 |
JP2002523062A (ja) | 2002-07-30 |
AU737087C (en) | 2005-05-12 |
AU737087B2 (en) | 2001-08-09 |
WO2000011221A1 (en) | 2000-03-02 |
AU5681399A (en) | 2000-03-14 |
EP1105537A4 (de) | 2002-08-14 |
CN1197975C (zh) | 2005-04-20 |
EP1105537A1 (de) | 2001-06-13 |
CN1312859A (zh) | 2001-09-12 |
IL141329A0 (en) | 2002-03-10 |
US20020164606A1 (en) | 2002-11-07 |
US6322988B1 (en) | 2001-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11530446B2 (en) | Methods and compositions for DNA profiling | |
US20210062186A1 (en) | Next-generation sequencing libraries | |
US20230392191A1 (en) | Selective degradation of wild-type dna and enrichment of mutant alleles using nuclease | |
US7169561B2 (en) | Methods, compositions, and kits for forming self-complementary polynucleotides | |
EP3115468B1 (de) | Erhöhung der verlässlichkeit von allel-aufrufen mit molekülzählung | |
US7192700B2 (en) | Methods and compositions for conducting primer extension and polymorphism detection reactions | |
US20190360034A1 (en) | Methods and systems for sequencing nucleic acids | |
US20090325183A1 (en) | Sequencing methods | |
Wittwer et al. | Nucleic acid techniques | |
ZA200100124B (en) | Method for determining polynucleotide sequence variations. | |
KR20210112350A (ko) | 다중 복제수 변이 검출 및 대립 유전자 비율 정량화를 위한 정량적 앰플리콘 서열분석 | |
US20200040390A1 (en) | Methods for Sequencing Repetitive Genomic Regions | |
US20030138834A1 (en) | Method for determining polynucleotide sequence variations | |
McEvoy | A comparison of the Illumina MiSeq FGX™ System against capillary electrophoresis in the analysis of two-person mixtures | |
CN117625739A (zh) | 同时进行基因组和甲基化组测序的测序接头组合物、建库方法和测序方法 | |
WO2004065634A1 (en) | Method for determining polynucleotide sequence variations | |
US20040121394A1 (en) | Method for determining polynucleotide sequence variations | |
Grisedale | Development of improved methods for low template DNA analysis | |
JP2006141347A (ja) | 高度好熱菌由来RecAタンパク質を用いた核酸塩基配列決定方法および核酸塩基配列決定キット |